Gender Differences in Passive Tension in Hypertrophic Cardiomyopathy Patients  by Nijenkamp, Louise L.A.M. et al.
346a Monday, February 17, 2014s is stress, ε is strain, and q is the phase shift. We found that both the viscous
modulus and the elastic modulus were higher in the AI KO at high fre-
quencies. These results suggest that WT passive tension levels rely on an
intact A-I junction; the removal of this region results in increased titin
stiffness.
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Background: A well-established function of titin is the determination of pas-
sive tension (Fpassive) in myocardium. Modifications to the elastic titin region
have been suggested to contribute to left ventricular (LV) diastolic dysfunction
in heart failure (HF). Titin-based stiffness can be modulated by isoform switch
or phosphorylation.
Results:We find that titin-isoform switch accounts for a significant amount of
myocardial stiffness modulation, giving rise to increased or reduced Fpassive in
different types of heart failure. In addition, both acute and chronic modula-
tions of cardiomyocyte Fpassive occur via altered titin phosphorylation. Cyclic
AMP-dependent protein kinase-A, cGMP-dependent protein kinase-G, and
extracellular signal-regulated kinase-2 phosphorylate titin at a cardiac-
specific domain, the N2Bus; this phosphorylation results in a reduction in car-
diomyocyte Fpassive in various species. PKCa phosphorylates the PEVK-
domain of titin, which increases Fpassive of normal mouse cardiomyocytes,
but does not significantly alter Fpassive of cardiomyocytes obtained from a
dog HF model. Calcium/calmodulin-dependent protein kinase-II (CaMKII)
is the first kinase found to phosphorylate both the N2Bus and the PEVK-
domain. This phosphorylation reduces cardiomyocyte Fpassive, as demonstrated
in skinned mouse cardiomyocytes incubated with recombinant CaMKIId.
Moreover, Fpassive is elevated in cardiomyocytes of CaMKIIg/d double
knockout mice and reduced in those of CaMKIId-overexpressing transgenic
mice. In both human and experimental HF, a global titin phosphorylation
deficit is observed, but site-specific titin phosphorylation can be increased
or decreased in HF, presumably depending on the activity and expression level
of the relevant kinases.
Conclusion: Titin phosphorylation may have beneficial effects in the heart
via reducing myocardial diastolic stiffness and improving ventricular
filling. Altered titin phosphorylation in HF may severely affect Fpassive and
compromise cardiac function. The degree, to which the different protein ki-
nases contribute to alterations in diastolic passive stiffness, needs to be
determined.
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Cardiac myosin binding protein C (cMyBP-C) is a sarcomeric protein involved
in the regulation of cardiac muscle contraction. Effects of cMyBP-C on
contraction are thought to be mediated in part by limiting the interactions of
actin and myosin to slow myocyte shortening velocity and power output.
Although interactions with myosin S2 on the thick filament have been proposed
as a way in which cMyBP-C could limit shortening velocity (e.g., by creating a
drag force on myosin heads), interactions of cMyBP-C with actin could also
account for slowed shortening velocity. For instance, cMyBP-C could create
a drag that opposes filament sliding by transiently linking thick and thin fila-
ments together. To explore this possibility we created transgenic mice that ex-
press a mutant cMyBP-C with a point mutation (L348P) located in a conserved
sequence within the regulatory M-domain that increases cMyBP-C binding to
actin in vitro (Bezold et al, JBC, 2013). We reasoned that if the mutation also
enhanced binding to actin in sarcomeres then shortening velocity would be
slowed in myocytes from L348P mice. Results show that transgenic mice ex-
pressing the L348P mutation are viable and that L348P cMyBP-C is expressed
in sarcomeres. Permeabilized myocytes from transgenic mice showed altered
force production including reduced maximal force and enhanced Ca2þ sensi-
tivity of tension. Shortening velocity and power output were significantly
reduced whereas passive stiffness and myocyte visco-elasticity were signifi-
cantly increased. Together these data are consistent with the idea that
cMyBP-C creates an internal load in the sarcomere by binding to actin. Thiswork supported by NIH R01 HL080367 (SPH) and an AHA graduate fellow-
ship (KLB).
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Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac
disorder. Mutations in the gene (MYBPC3) encoding cardiac myosin binding
protein C (cMyBP-C) are a frequent cause of HCM. Clinical as well as
animal-model studies have reported sex-related differences in HCM disease
onset and severity. In addition, it has been established that physiological
stimuli such as exercise may elicit a sexually dimorphic cardiac response.
However, less attention has been paid to the sex-specific differences in the
cellular pathophysiologic mechanisms underlying HCM. Therefore, we
studied functional properties of the heart and sarcomeres in male and
female sedentary and exercise (exposed to 8 weeks voluntary wheel running)
mice.
Echocardiography and isometric force measurements in mechanically isolated
left ventricular (LV) membrane-permeabilized cardiomyocytes were per-
formed in Wild-type (WT) and heterozygous (HET) knock-in mice carrying
a Mybpc3 point mutation (G>A transition) associated with HCM.
The LV mass was significantly lower in female WT and HET mice (23% in
WT and 25% in HET), compared to corresponding male mice. Isometric
force measurements revealed a significant lower maximal generated tension
(Fmax) in HET male (13.0 51.1 kN/m
2), than in females (20.0 52.2 kN/
m2). Exercise induced a higher fractional shortening in HET male mice,
which is correlated with an increased Fmax in exercised HET males. In
contrast, LV weight was significantly increased in exercised HET females
compared to sedentary females (7% in WT and 15% in HET). Ca2þ-sensi-
tivity was increased in exercised male and females WT mice. Similarly,
Ca2þ-sensitivity was enhanced in HET females, however not in exercised
HET mice.
In conclusion, exercise training improved cardiac and myofilament perfor-
mance particularly in HET male mice, indicating that physiological stimuli
may elicit a sexually dimorphic cardiac response in heterozygous Mybpc3-tar-
geted knock-in mice.
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Background
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder with a
prevalence of 1:500. In ~65% of all HCM patients the causative mutation is
identified. HCM patients that are sarcomere-mutation negative tend to have a
less severe phenotype. Mutations in the MYBPC3 and MYH7 genes encoding
cardiac myosin-binding protein C (cMyMP-C) and b-myosin heavy chain
(MyHC) represent >80% of all genotyped HCM cases. HCM is characterized
by asymmetric hypertrophy of the left ventricle and diastolic dysfunction. In
the present study we investigated if passive stiffness of the sarcomeres may un-
derlie diastolic dysfunction.
Methods
In-vitro passive tension measurements were done at sarcomere lengths of 1.8 to
2.2mm in cardiomyocytes from 10 sarcomere mutation-negative patients(SMN:
5 male, 5 female), 17 patients carrying a MYBPC3 mutation(MYBPC3: 10
male, 7 female), and 10 patients carrying a MYH7 mutation (MYH7: 5 male,
5 female). Tissue was obtained during myectomy surgery from the interventric-
ular septum. Cardiomyocytes were mechanically isolated and Triton-
permeabilized.
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Passive tension over the entire range of sarcomere lengths did not differ be-
tween sarcomere-mutation positive and mutation-negative male HCM patients.
Passive tension in myocytes from sarcomere mutation-positive women was
significantly higher compared to female mutation-negative HCM patients. Fe-
male MYH7 cardiomyocytes showed a higher sarcomere stiffness compared to
male MYH7.
Conclusion
Our measurements suggest that high sarcomere passive stiffness may
contribute to diastolic dysfunction in female HCM patients harboring a muta-
tion in genes encoding thick filament proteins.
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Mammalian hearts express two myosin heavy chain (MHC) isoforms, which
drive contractions with different kinetics and power-generating ability. The
expression of the isoform that is associated with more rapid contraction kinetics
and greater power output, MHC-a, is down-regulated, with a concurrent in-
crease in the relative amount of the slower isoform, MHC-b, during the pro-
gression to experimentally-induced or disease-related heart failure. This
change in protein expression has been well studied in right and left ventricles
in heart failure models and in humans with failure. Relatively little quantitative
data exists regarding MHC isoform expression shifts in human failing atria. We
previously reported significant increases in the relative amount of MHC-b in
the human failing left atrium. The results of that study suggested that there
might be a sex-related difference in the level of MHC-b in the left atrium,
but the number of female subjects was insufficient for statistical analysis.
The objective of this study was to test whether there is, in fact, a sex-related
difference in the level of MHC-b in the right and left atria of humans with car-
diomyopathy. The results indicate that significant differences exist in atrial
MHC isoform expression between men and women who are in failure. The re-
sults unexpectedly also revealed a two-fold greater amount of MHC-b in the
non-failing left atrium of women, compared to men. The observed sex-
related differences in MHC isoform expression could impact ventricular dia-
stolic filling during normal daily activities, as well as during physiologically
stressful events.
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Rationale: Myocardial infarction (MI) is associated with depressed cardiac con-
tractile function and progression to heart failure. Cardiac myosin binding
protein-C (cMyBP-C), a cardiac-specific myofilament protein, is proteolyzed
post-MI in humans and results in an N-terminal fragment, C0C1f. The presence
of C0C1f in cultured adult cardiomyocytes results in decreased Ca2þ transients
and cell shortening, in addition to the induction of heart failure in a mouse
model. However, the underlying mechanisms remain unclear.
Objective: To determine how C0C1f causes altered contractility in human car-
diac myofilaments in vitro.
Methods and Results: We generated recombinant human C0C1f (hC0C1f) and
incorporated it into skinned human left ventricular myocytes. Mechanical prop-
erties were then studied at sarcomere lengths of 2.0 and 2.3 mm. Our data
demonstrate that the presence of hC0C1f in the sarcomere decreased maximal
force myofilament Ca2þ sensitivity, increased cooperative activation at short
lengths and enhanced length-dependent activation. Furthermore, hC0C1f led
to increased cross-bridge cycling kinetics and tension cost at both short and
long sarcomere lengths. We further established that the detrimental effects of
hC0C1f occur through direct interaction with the thin filament proteins actin
and a-tropomyosin (a-TM).Conclusions: Our data demonstrate that the presence of hC0C1f in the sarco-
mere is sufficient to induce depressed myofilament function and Ca2þ sensi-
tivity in otherwise healthy human donor myofilament preparations.
Decreased cardiac function post-MI may result, in part, from the ability of
hC0C1f to bind actin and a-TM, suggesting that cleaved C0C1f could act as
a poison peptide and disrupt the interaction of native cMyBP-C with the thin
filament.
Keywords: Cross-bridge cycling kinetics; length-dependent activation;
cMyBP-C; C0C1f protein.
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Background: Rest or exercise obstruction is present in two thirds of patients
with hypertrophic cardiomyopathy (HCM) and is a major determinant of symp-
toms and disability. Hypercontractile upper septum is the main pathophysiolog-
ical determinant of obstruction, thus negative inotropic interventions such as
dysopiramide or beta-blockers are the only available options to pharmacolog-
ically treat obstruction, commonly with partial efficacy. We have previously
demonstrated that ranolazine ameliorates diastolic function in trabeculae
from septal samples of obstructive HCM patients undergoing myectomy (Cop-
pini et al, Circulation 2013).
Methods: Patch clamp studies and intracellular Ca2þ recordings were per-
formed in isolated myocytes from myectomy samples of obstructive HCM pa-
tients; intact trabeculae were used for mechanical measurements. Myocardial
specimens from non-failing non-hypertrophic patients or patients with second-
ary hypertrophy were used as controls.
Results: Dysopiramide (Dys) reduced twitch tension in a dose dependent
manner and 5mM Dys accelerated contraction kinetics in HCM trabeculae.
Isoproterenol 107 mol/L (Iso) determined a significant potentiation of twitch
amplitude and an accelleration of contraction kinetics (both time to peak and
relaxation). Changes induced by Iso in control trabeculae were similar. Inter-
estingly, Iso caused APD prolongation in HCM cardiomyocytes instead of
the shortening observed in control cells. This was likely related to the unbal-
ance between depolarizing and repolarizing currents, including increased
Late-Naþ current (INaL). The INaL blocker Ranolazine 10 mM (Ran) applied
on top of Iso (IsoþRan) markedly reduced isometric twitch tension of
HCM trabeculae, while Ran alone showed no negative inotropic effect.
Contraction kinetics in IsoþRan were still significantly faster compared to
baseline.
Conclusions: Beta adrenergic stimulation may enhance septal contractility
and determine obstruction in HCM. Ranolazine, by reducing septal tension at
peak exercise but not at rest, may represent a safe therapeutic option for
obstruction.
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We examined the role of missense and nonsense myosin-binding protein
mutations in human tissue of patients with hypertrophic cardiomyopathy
in an essentially unloaded isotonic system by partial Ca2þ-activation, i.e.
Ca-spontaneous oscillary contractions (SPOC). Despite considerable litera-
ture suggesting that hypercontractility is a feature of HCM-causing muta-
tions, we observe: (1) prolonged durations of both the lengthening
(p<0.0001) and shortening (p<0.001) phases of the SPOC cycle in
MYBPC3 mutants; (2) depressed contractility where the rates of both
lengthening (P<0.01) and shortening (p<0.05) were reduced; however (3)
the amplitude of the SPOC cycles did not vary between mutated MYBPC3
and healthy donor samples under essentially unloaded isotonic conditions.
We found no difference between MYBPC3 samples containing missense
or nonsense mutations. Unexpectedly, principal component analysis demon-
strated that the contractile properties of human derived cardiomyocytes un-
der low-load conditions were distinctively different for mutations in
MYBPC3 and troponin genes. We conclude that, at least under the isotonic
